Automated cellient™ cytoblocks: Better, stronger, faster?

Cytopathology

Volumn 25, Issue 6, 2014, Pages 372-380

  Prendeville, S ^a   Brosnan, T ^a   Browne, T J ^a   Mccarthy, J ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Cell block; Cellient; Cytoblock; Cytological techniques; Immunocytochemistry

Indexed keywords

CD45 ANTIGEN; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; EOSIN; FORMALDEHYDE; HEMATOXYLIN; MELAN A; PROTEIN P63;

ANALYTICAL EQUIPMENT; ARTICLE; AUTOMATION; CANCER CELL; CELL STRUCTURE; CELLIENT AUTOMATED CELL BLOCK SYSTEM; CELLULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOBLOCK; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; LABORATORY TEST; PRIORITY JOURNAL; SCORING SYSTEM; CYTODIAGNOSIS; FINE NEEDLE ASPIRATION BIOPSY; IMMUNOHISTOCHEMISTRY; NEOPLASMS; PATHOLOGY; PROCEDURES; TISSUE FIXATION;

BIOPSY, FINE-NEEDLE; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; TISSUE FIXATION;

EID: 84912042898     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12159     Document Type: Article

References (18)

1. Mayall F, Chang B, Darlington A. A review of 50 consecutive cytology cell block preparations in a large general hospital. J Clin Pathol 1997;50:985-90.
2. Schmitt F, Barroca H. Role of ancillary studies in fine-needle aspiration from selected tumors. Cancer Cytopathol 2012;120:145-60.
3. Nigro K, Tynski Z, Wasman J, Abdul-Karim F, Wang N. Comparison of cell block preparation methods for nongynecologic ThinPrep specimens. Diagn Cytopathol 2007;35:640-3.
4. Cellient™ Automated Cell Block System Operator's Manual. Cytyc Corporation, a Hologic company, Marlborough, MA, 2008. Available at: http://www.cellientsystem.com. (Accessed 28 April 2012).
5. Thepar M, Mishra RK, Sharma A, Goyal V. Critical analysis of cell block versus smear examination in effusions. J Cytol 2009;26:60-4.
6. ™ automated cell block versus traditional cell block preparation: a comparison of morphologic features and immunohistochemical staining. Diagn Cytopathol 2011;39:730-6.
7. UKNEQAS for Immunocytochemistry and In Situ Hybridisation. Participant's manual 2011, 2012; 3-5, London, UK.
8. Shabaik A, Lin G, Peterson M et al. Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma. Diagn Cytopathol 2011;39:328-32.
9. Loukeris K, Vazquez MF, Sica G et al. Cytological cell blocks: predictors of squamous cell carcinoma and adenocarcinoma subtypes. Diagn Cytopathol 2012;40:380-7.
10. Gorman BK, Kosarac O, Chakraborty S, Schwartz MR, Mody DR. Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin. Acta Cytol 2012;56:289-96.
11. Akalin A, Lu D, Woda B, Moss L, Fischer A. Rapid cell blocks improve accuracy of breast FNAs beyond that provided by conventional cell blocks regardless of immediate adequacy evaluation. Diagn Cytopathol 2008;36:523-9.
12. ™) automated cell block processor to diagnostic cytopathology, immunocytochemistry, and molecular biology. Diagn Cytopathol 2013;41:734-41.
13. Hammond ME, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 2010;134:907-22.
14. Wolff AC, Hammond ME, Hicks DG et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 2014;138:241-56.
15. Lindeman NI, Cagle PT, Beasley MB et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 2013;137:828-60.
16. Wong C, DiCioccio RA, Allen HJ, Werness BA, Piver MS. Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation. Cancer Genet Cytogenet 1998;107:21-7.
17. Akbari M, Hansen MD, Halgunset J, Skorpen F, Krokan HE. Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner. J Mol Diagn 2005;7:36-9.
18. Williams C, Ponten F, Moberg C et al. A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am J Pathol 1999;155:1467-71.